Follow
Immunotherapy
Immunotherapy: is a type of cancer treatment the helps the immune system to fight cancer. The immune system helps your body fight infections and other diseases. It uses substances made by the body or in a laboratory in order to improve or restore the body's immune system function.
What's Popular in Immunotherapy
-
MAY 30, 2023Drug Discovery & DevelopmentIntroduction Antibodies are the ideal therapeutic biomolecules due to their ability to bind to a variety of targets with ...MAY 15, 2023Cancer
Cardiotoxicity, damage to the heart or cardiovascular system, occurs as an unfortunate side effect associated with many ...Written By: Katie KokolusMAY 10, 2023Immunology
Myeloid-derived suppressor cells (MDSCs) are immune cells that promote chronic inflammatory disease, such as triple nega ...Written By: Brian G. MorrealeMAY 09, 2023Immunology
Cancer immunotherapy constantly evolves, and discoveries and treatments targeting more aggressive cancers are published ...Written By: Brian G. MorrealeAPR 25, 2023Cancer
Renal cell carcinoma (RCC), also known as kidney cancer, forms in the tubules of the kidney, the part of the organ that ...Written By: Katie Kokolus
MAY 30, 2023
Drug Discovery & Development
Introduction Antibodies are the ideal therapeutic biomolecules due to their ability to bind to a variety of targets with
...
MAY 15, 2023
Cancer
Cardiotoxicity, damage to the heart or cardiovascular system, occurs as an unfortunate side effect associated with many
...
Written By:
Katie Kokolus
MAY 10, 2023
Immunology
Myeloid-derived suppressor cells (MDSCs) are immune cells that promote chronic inflammatory disease, such as triple nega
...
Written By:
Brian G. Morreale
MAY 09, 2023
Immunology
Cancer immunotherapy constantly evolves, and discoveries and treatments targeting more aggressive cancers are published
...
Written By:
Brian G. Morreale
APR 25, 2023
Cancer
Renal cell carcinoma (RCC), also known as kidney cancer, forms in the tubules of the kidney, the part of the organ that
...
Written By:
Katie Kokolus
APR 17, 2023
Cancer
Endometrial cancer, characterized by the formation of malignant cells in the endometrium, the tissue that lines the insi
...
Written By:
Katie Kokolus
APR 11, 2023
Cancer
Monoclonal antibodies have revolutionized cancer therapy since their introduction as therapeutics in the field. To enhan
...
Sponsored By:
Sino Biological
MAR 29, 2023
Health & Medicine
By harnessing a cellular process called autophagy, researchers at hope to boost our body's ability to protect against in
...
Written By:
Amielle Moreno
MAR 29, 2023
Clinical & Molecular DX
A new review paper, which takes a broad view of research developments in a field, has suggested that the circadian rhyth
...
Written By:
Carmen Leitch
-
MAY 16, 2023 | 8:00 AM
The therapeutic use of chimeric antigen receptor T cells has achieved significant success in the treatment of B cells malignancies. Despite promising results in mouse tumor models, a similar...MAY 02, 2023 | 8:00 AMC.E. CREDITS
Abstract Learning Objectives Define a tertiary lymphoid structure in human cancer Describe the tumor microenvironment factors that influence the formation of tertiary lymphoid structures Ide...APR 25, 2023 | 8:00 AMC.E. CREDITS
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Several promising immunotherapies have emerged in recent decades due to advances in cancer immunology. The paradigm o...MAR 30, 2023 | 5:00 PM
Date: March 30, 2023 Time: 5:00pm (PST), 8:00pm (EST) March 31, 2023 9:00am (JST) Chimeric antigen receptor T cell (CAR-T) therapy is still challenging in targeting solid malignancies. The q...MAR 30, 2023 | 1:00 PMC.E. CREDITS
The circulating T-cell receptor (TCR) repertoire is a dynamic representation of overall immune responses in an individual. Here we aimed to correlate pre-treatment circulating TCR repertoire...Speaker: Elin Gray, BSc, MSc, PhDPresented at: OncomineWorld 2023: A Virtual NGS Education Meeting
MAY 16, 2023 | 8:00 AM
The therapeutic use of chimeric antigen receptor T cells has achieved significant success in the treatment of B cells malignancies. Despite promising results in mouse tumor models, a similar...
MAY 02, 2023 | 8:00 AM
C.E. CREDITS
Abstract Learning Objectives Define a tertiary lymphoid structure in human cancer Describe the tumor microenvironment factors that influence the formation of tertiary lymphoid structures Ide...
APR 25, 2023 | 8:00 AM
C.E. CREDITS
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Several promising immunotherapies have emerged in recent decades due to advances in cancer immunology. The paradigm o...
MAR 30, 2023 | 5:00 PM
Date: March 30, 2023 Time: 5:00pm (PST), 8:00pm (EST) March 31, 2023 9:00am (JST) Chimeric antigen receptor T cell (CAR-T) therapy is still challenging in targeting solid malignancies. The q...
MAR 30, 2023 | 1:00 PM
C.E. CREDITS
The circulating T-cell receptor (TCR) repertoire is a dynamic representation of overall immune responses in an individual. Here we aimed to correlate pre-treatment circulating TCR repertoire...
Speaker:
Elin Gray, BSc, MSc, PhD
Presented at: OncomineWorld 2023: A Virtual NGS Education Meeting
NOV 16, 2022 | 7:00 PM
C.E. CREDITS
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
NOV 03, 2022 | 6:00 AM
Date: October 13, 2022 Time: 10:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Most known immune checkpoints exert their effects upon protein-protein interactions, such as the PD1 checkpoint on CD...
OCT 26, 2022 | 8:00 AM
Date: October 26, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Immunotherapy has transformed the treatment of metastatic and recurrent solid tumors. Advances in technology in the pa...
OCT 19, 2022 | 1:30 PM
C.E. CREDITS
COVID-19 remains a global health emergency with limited treatment options, lagging vaccine rates, and inadequate healthcare resources in the face of an ongoing calamity. The disease is chara...
-
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...
Labroots is pleased to announce the 11th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This 3 day event will take place on October 3-5, 2023....
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...MAR 01, 2023 | 10:00 AM PST
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...JAN 31, 2023 | 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...
Labroots is pleased to announce the 11th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This 3 day event will take place on October 3-5, 2023....
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
MAR 01, 2023
| 10:00 AM PST
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
JAN 31, 2023
| 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...
OCT 04, 2022
| 5:30 AM PDT
C.E. CREDITS
Labroots to host the 10th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This two day event will take place on October 4-6, 2022....
OCT 06, 2021
| 5:30 AM PDT
C.E. CREDITS
Labroots and the Cancer Research and Oncology Planning Committee are pleased to announce the 9th Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
SEP 14, 2021
| 12:00 AM PDT
Europe - 9:00 AM Central European Summer Time Americas - 9:00 AM Central Daylight Time Asia-Pacific - 9:00 AM Beijing Standard Time (*September 15) ADVANCING SCIENCE: A VIRTUAL IMMUNOLOGY CO...